1-Pyrrolidinepropanol, alpha-(2,3-dihydro-1,4-benzodioxin-6-yl)-beta-[[(1S)-2-hydroxy-1-phenylethyl]amino]-, (alphaR,betaR)

It provides the essential stereochemically defined backbone required for the drug’s biological activity, particularly contributing to the correct spatial arrangement of the amine and hydroxyl functional groups. During synthesis, this intermediate undergoes further functional group modifications and coupling steps to construct the final eliglustat molecule, which is then converted into its tartrate salt form to improve stability and bioavailability. The compound 1-Pyrrolidinepropanol, α-(2,3-dihydro-1,4-benzodioxin-6-yl)-β-[[(1S)-2-hydroxy-1-phenylethyl]amino]-, (αR,βR) serves as a key chiral intermediate in the synthesis of eliglustat tartrate.

API Name Eliglustat tartrate
CAS No 491833-27-3
Molecular Formula C23H30N2O4
Molecular Weight 398.5 g/mol
Synonyms 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[(2-hydroxy-1-phenylethyl)amino]-3-pyrrolidin-1-ylpropan-1-ol

Frequently Asked Questions